Answers are grounded in this paper and cite their sources.
The advent of Anti-Retroviral Therapy (ART) has resulted in remarkable improvement in the management of Human Immuno-deficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS). Adherence to ART and other HIV and AIDS treatment modalities amongst HIV seropositive mothers has resulted in a reduction in the rate of Mother-To-Child Transmission (MTCT) of HIV. Nonetheless, MTCT of HIV rates remain high in Homa Bay County, Kenya, with 8.8% MTCT of HIV. This rate is higher than the World Health Organization (WHO) target of reducing MTCT of HIV to less than 5%. The study assessed maternal determinants of Prevention of Mother-to-Child Transmission (PMTCT) of HIV among HIV seropositive women on PMTCT follow-up at Homa Bay County Referral Hospital. An analytical cross-sectional design was used on a total of 274 women recruited in the study. A structured questionnaire assessed for maternal-related factors associated with PMTCT outcomes. Data on PMTCT outcomes were abstracted from files of HIV Exposed Infants (HEI) whose mothers were enrolled in the study. A total of 273 participants completed the study (response rate: 99.6%). The mean age of the study participants was 32.16 (± 5.54 SD). There was a significant association between maternal factors, reason for missed clinic visit, missed ART intake, reasons for missed ART intake, and missing to provide ART prophylaxis to infant/child and PMTCT outcome at α ≤ 0.05 (p = 0.002, p = 0.005, p = 0.006, and p = 0.05, respectively). Reason for missed clinic visit and reason for missed ART intake demonstrated 5.1 and 5.8 times increase in odds of determining PMTCT outcome (OR = 5.122, 95% CI: 0.139-189.53; p = 0.002) and (OR = 5.751, 95% CI: 0.615-53.781; p = 0.006), respectively. Maternal factors attributable to the reason for missed clinic visits and the reason for missed ART intake were the main determinants of PMTCT outcomes; hence, they are essential in the development of intervention strategies to mitigate MTCT of HIV
No takes yet. Share an insight, caveat, or question.
Osoti et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: